TLR4 and hepatocellular carcinoma: Notably, IL‐1β expression is associated with TLR4, and the Dox combining CD55‐TMn promoted IL‐1β expression in HCC cell, suggesting the combination of CD55‐TMn and Dox has the ability to combine immunogenicity with oncolysis.